Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

1,274 total articles

Future Money Acquisition Corporation Announces Completion of $112,000,000 Initial Public Offering, Including Partial Exercise of Overallotment Option

Future Money Acquisition Corporation Announces Completion of $112,000,000 Initial Public Offering, Including Partial Exercise of Overallotment Option

Future Money Acquisition Corporation, a Cayman Islands-based blank check company, successfully completed its IPO by offering 11.2 million units at $10 each, including a partial exercise of the underwriters' overallotment option. The company raised gross proceeds of $112 million and concurrently closed a private placement for an additional $3 millio…

Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

Glucotrack, Inc. reported its 2025 financial results and significant corporate progress including the receipt of three new U.S. patents for its implantable continuous blood glucose monitoring (CBGM) technology, a $4 million private placement, and preparations to file for Investigational Device Exemption (IDE) with the FDA to launch U.S. clinical tr…

Oxbridge Highlights Strong 2025–26 Performance, Platform Expansion, and Market Opportunity; Reports Q4 and Full-Year Results

Oxbridge Highlights Strong 2025–26 Performance, Platform Expansion, and Market Opportunity; Reports Q4 and Full-Year Results

Oxbridge Re Holdings Limited reported strong financial results for 2025, highlighting outperforming tokenized reinsurance products and strategic platform expansion. The Balanced Yield Token surpassed its 20% annual return target, now estimated at 25%, and the High Yield Token remains on track for 42% returns. The company expanded its ecosystem thro…

BIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Bio Green Med Solution, Inc. (NASDAQ: BGMS) announced its Q4 and full-year 2025 financial results, highlighting a strategic shift from biopharmaceuticals to fire safety protection and distribution activities following the acquisition of Fitters Sdn. Bhd. The company completed the liquidation of its UK subsidiary and sold its drug candidate plogoser…

DeFi Development Corp. Reports +442% Revenue Growth for FY 2025

DeFi Development Corp. Reports +442% Revenue Growth for FY 2025

DeFi Development Corp. reported a remarkable 442% revenue increase for fiscal year 2025. The company attributes this growth to its unique treasury strategy focused on accumulating and compounding Solana (SOL) holdings, operational validator infrastructure generating staking rewards, and its AI-powered SaaS platform serving the commercial real estat…

Rocket Lab Receives Regulatory Approval to Acquire Mynaric

Rocket Lab Receives Regulatory Approval to Acquire Mynaric

Rocket Lab Corporation has obtained regulatory approval from Germany's Federal Ministry for Economic Affairs and Energy to acquire Mynaric AG, a leading provider of laser optical communications terminals for air, space, and mobile applications. The acquisition is expected to close in April 2026 and will enable Rocket Lab to expand its support of Ge…

Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54

Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54

BridgeBio Pharma reported compelling long-term data from its ATTRibute-CM open-label extension trial showing that acoramidis significantly reduces all-cause and cardiovascular mortality by approximately 45% and 49%, respectively, in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) through 54 months. The treatment also stabilize…

HII and GrayMatter Robotics to Advance Shipbuilding with Physical AI

HII and GrayMatter Robotics to Advance Shipbuilding with Physical AI

HII, America's largest shipbuilder, has signed a memorandum of understanding with GrayMatter Robotics to advance shipbuilding through Physical AI technology. This partnership aims to enhance manufacturing automation, increase throughput, and reduce rework in shipbuilding and related industries using cutting-edge AI robotics solutions developed by G…

FitLife Brands Announces Fourth Quarter Earnings Call

FitLife Brands Announces Fourth Quarter Earnings Call

FitLife Brands announced it will release its fourth quarter fiscal 2025 financial results on March 31, 2026, followed by an investor conference call on April 1, 2026. The company specializes in nutritional supplements and wellness products and distributes over 500 SKUs online and in retail.

DeFi Technologies Announces the Appointment of Jacob Lindberg as Chief Revenue Officer of Valour to Lead Nordic and European Expansion

DeFi Technologies Announces the Appointment of Jacob Lindberg as Chief Revenue Officer of Valour to Lead Nordic and European Expansion

DeFi Technologies Inc. has appointed Jacob Lindberg as Chief Revenue Officer of its subsidiary Valour to lead the Nordic and broader European expansion of its crypto asset exchange traded products (ETPs). Lindberg's expertise in digital asset indices and institutional investment products is expected to support Valour's growth in key European market…

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

Ferrari N.V. has disclosed its periodic share repurchase activities under the first tranche of its announced €3.5 billion multi-year buyback program, detailing purchases on both Euronext Milan and the New York Stock Exchange. Since the program's start in January 2026 through March, Ferrari acquired over 737,000 shares, investing approximately €217 …

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

Viewbix: Quantum X Labs Announces Strategic Milestone in Advancing Quantum-Powered Nuclear Simulation

Viewbix Inc., through its subsidiary Quantum X Labs and its portfolio company Nuclear Quantum, has reached a strategic milestone by progressing its proprietary quantum simulation algorithms towards targeted collaborations with established nuclear simulation companies. This initiative aims to modernize legacy simulation methods by integrating quantu…

Workhorse Announces 100 Vehicle Purchase Order from Purolator

Workhorse Announces 100 Vehicle Purchase Order from Purolator

Workhorse Group Inc. announced a purchase order from Purolator for 100 fully-electric step vans, doubling Purolator's electric vehicle fleet supplied by Workhorse. The deliveries will take place throughout 2026, strengthening the long-term partnership between the companies. Workhorse's manufacturing and operational scale supports its growing presen…

Jeffs’ Brands Announces Corporate Name Change to Nexera Technologies and New Nasdaq Ticker Symbol “NEXR”

Jeffs’ Brands Announces Corporate Name Change to Nexera Technologies and New Nasdaq Ticker Symbol “NEXR”

Jeffs' Brands Ltd has officially changed its corporate name to Nexera Technologies Ltd, reflecting a strategic pivot toward advanced technology and homeland security solutions including AI-driven threat detection and advanced screening systems. The company's shares will begin trading under the new ticker NEXR on Nasdaq. This rebranding and strategi…

Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones

Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones

Immix Biopharma announced completion of enrollment in its pivotal NEXICART-2 Phase 2 trial for relapsed/refractory AL Amyloidosis. Topline results are expected in Q3 2026, followed by Biologics License Application (BLA) submission and planned commercial launch of their lead CAR-T therapy, NXC-201. The company also appointed a new Chief Medical Offi…

Clean Energy Technologies Advances First Waste-to-Energy Deployment in Alberta Under LOI with Hoppy Power, Targeting Scalable Rollout

Clean Energy Technologies Advances First Waste-to-Energy Deployment in Alberta Under LOI with Hoppy Power, Targeting Scalable Rollout

Clean Energy Technologies, Inc. (CETY) has entered a non-binding Letter of Intent with Hoppy Power Ltd. to evaluate and advance deployment of its High Temperature Ablative Pyrolysis (HTAP™) technology for waste-to-energy projects, with an initial site identified in Westlock, Alberta. The project aims to convert waste into clean energy with modular …

Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder

Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder

Clearmind Medicine announced the successful completion of treatment and follow-up for 18 participants in its ongoing FDA-approved Phase I/IIa clinical trial of CMND-100, a non-hallucinogenic MEAI-based oral drug candidate for Alcohol Use Disorder. The progress includes treatment of four additional participants at the Tel Aviv site, demonstrating op…

SUNation Energy Installs 10,000th Solar System, Surpasses 130 MW of Installed Clean Energy Capacity Across Long Island

SUNation Energy Installs 10,000th Solar System, Surpasses 130 MW of Installed Clean Energy Capacity Across Long Island

SUNation Energy, Inc., a Nasdaq-listed provider of sustainable solar solutions, announced the completion of its 10,000th solar system installation, surpassing 130 megawatts of total solar capacity across Long Island. This milestone highlights over two decades of commitment to advancing clean energy adoption, contributing an estimated $42 million in…

JFB Announces XTEND Becomes First U.S. Company to Receive U.S. Army Safety Board Approval for FPV Drone Programs

JFB Announces XTEND Becomes First U.S. Company to Receive U.S. Army Safety Board Approval for FPV Drone Programs

XTEND, through JFB Construction Holdings, has received limited operational assessment approval from the U.S. Army Fuze Safety Board for its high-voltage safety and arming system designed for First-Person View (FPV) attack drones. This milestone positions XTEND as the first U.S. company to obtain such approval, underscoring its leadership in AI-powe…